| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 17.96% | Morgan Stanley | $37 → $40 | Maintains | Overweight |
| 11/07/2023 | 9.11% | Benchmark | → $37 | Reiterates | Buy → Buy |
| 08/10/2023 | 9.11% | Benchmark | $35 → $37 | Maintains | Buy |
| 08/10/2023 | 9.11% | Morgan Stanley | $34 → $37 | Maintains | Overweight |
| 08/08/2023 | 3.21% | Benchmark | $33 → $35 | Maintains | Buy |
| 07/13/2023 | -2.68% | Benchmark | → $33 | Reinstates | Buy → Buy |
| 06/21/2023 | -5.63% | Benchmark | → $32 | Upgrades | Hold → Buy |
| 04/25/2023 | -5.63% | Stephens & Co. | → $32 | Reiterates | → Overweight |
| 02/08/2023 | 0.27% | Morgan Stanley | $29 → $34 | Maintains | Equal-Weight |
| 02/08/2023 | 3.21% | Susquehanna | $30 → $35 | Maintains | Positive |
| 02/08/2023 | -5.63% | Stephens & Co. | $28 → $32 | Maintains | Overweight |
| 11/09/2022 | -14.48% | Morgan Stanley | $32 → $29 | Maintains | Overweight |
| 10/19/2022 | -5.63% | Morgan Stanley | $36 → $32 | Maintains | Overweight |
| 09/20/2022 | — | Benchmark | Initiates Coverage On | → Hold | |
| 08/08/2022 | 35.65% | Wells Fargo | $65 → $46 | Maintains | Overweight |
| 08/05/2022 | 32.7% | Susquehanna | $50 → $45 | Maintains | Positive |
| 07/14/2022 | 12.06% | Morgan Stanley | $41 → $38 | Maintains | Overweight |
| 05/26/2022 | 20.91% | Morgan Stanley | $63 → $41 | Maintains | Overweight |
| 05/25/2022 | 47.45% | Susquehanna | $90 → $50 | Maintains | Positive |
| 05/25/2022 | 71.04% | Stephens & Co. | $67 → $58 | Maintains | Overweight |
| 03/15/2022 | 41.55% | BMO Capital | → $48 | Upgrades | Market Perform → Outperform |
| 02/10/2022 | 85.79% | Morgan Stanley | $69 → $63 | Maintains | Overweight |
| 02/10/2022 | 150.66% | Wells Fargo | $95 → $85 | Maintains | Overweight |
| 12/16/2021 | 103.48% | Morgan Stanley | $93 → $69 | Maintains | Overweight |
| 11/03/2021 | 168.36% | Needham | $82 → $91 | Maintains | Buy |
| 05/26/2021 | 141.82% | Craig-Hallum | $100 → $82 | Maintains | Buy |
| 05/26/2021 | 127.07% | Needham | $88 → $77 | Maintains | Buy |
| 03/04/2021 | 91.68% | BMO Capital | $80 → $65 | Downgrades | Outperform → Market Perform |
| 02/09/2021 | 194.9% | Craig-Hallum | $80 → $100 | Maintains | Buy |
| 02/09/2021 | 165.41% | Susquehanna | $85 → $90 | Maintains | Positive |
| 02/09/2021 | 174.26% | Morgan Stanley | $85 → $93 | Maintains | Overweight |
| 02/09/2021 | 159.51% | Needham | $85 → $88 | Maintains | Buy |
| 11/17/2020 | 103.48% | Morgan Stanley | $65 → $69 | Maintains | Overweight |
| 11/10/2020 | 150.66% | Needham | $61 → $85 | Maintains | Buy |
| 08/11/2020 | 91.68% | Morgan Stanley | $52 → $65 | Maintains | Overweight |
| 08/11/2020 | 79.89% | Needham | $57 → $61 | Maintains | Buy |
| 07/09/2020 | 91.68% | Craig-Hallum | → $65 | Initiates Coverage On | → Buy |
| 06/24/2020 | 68.09% | Needham | $53 → $57 | Maintains | Buy |
| 05/22/2020 | 53.35% | Morgan Stanley | $48 → $52 | Maintains | Overweight |
| 05/22/2020 | 56.3% | Needham | $57 → $53 | Maintains | Buy |
| 04/27/2020 | 68.09% | Needham | $70 → $57 | Maintains | Buy |
| 03/25/2020 | 41.55% | Morgan Stanley | $64 → $48 | Maintains | Overweight |
| 03/11/2020 | 76.94% | Stephens & Co. | $56 → $60 | Maintains | Overweight |
| 02/11/2020 | 65.14% | Stephens & Co. | $61 → $56 | Maintains | Overweight |
| 02/06/2020 | 106.43% | Needham | $67 → $70 | Maintains | Buy |
| 12/20/2019 | 97.58% | Needham | → $67 | Initiates Coverage On | → Buy |
| 11/07/2019 | 76.94% | Morgan Stanley | $58 → $60 | Maintains | Overweight |
| 10/16/2019 | 71.04% | Morgan Stanley | $64 → $58 | Maintains | Overweight |
| 09/20/2019 | — | First Analysis | Upgrades | Outperform → Strong Buy | |
| 07/16/2019 | 88.73% | Morgan Stanley | → $64 | Initiates Coverage On | → Overweight |
| 07/15/2019 | 88.73% | Morgan Stanley | → $64 | Initiates Coverage On | → Overweight |
| 06/26/2019 | 106.43% | Susquehanna | → $70 | Initiates Coverage On | → Positive |
| 05/29/2019 | — | First Analysis | Upgrades | Neutral → Outperform | |
| 12/21/2018 | 76.94% | Wells Fargo | → $60 | Reinstates | → Outperform |
What is the target price for LiveRamp Holdings (RAMP)?
The latest price target for LiveRamp Holdings (NYSE: RAMP) was reported by Morgan Stanley on November 9, 2023. The analyst firm set a price target for $40.00 expecting RAMP to rise to within 12 months (a possible 17.96% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LiveRamp Holdings (RAMP)?
The latest analyst rating for LiveRamp Holdings (NYSE: RAMP) was provided by Morgan Stanley, and LiveRamp Holdings maintained their overweight rating.
When is the next analyst rating going to be posted or updated for LiveRamp Holdings (RAMP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LiveRamp Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LiveRamp Holdings was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating LiveRamp Holdings (RAMP) correct?
While ratings are subjective and will change, the latest LiveRamp Holdings (RAMP) rating was a maintained with a price target of $37.00 to $40.00. The current price LiveRamp Holdings (RAMP) is trading at is $33.91, which is out of the analyst's predicted range.